Rabab Nasrallah

Investment Associate at Earlybird Venture Capital

Rabab Nasrallah is an investment professional at Earlybird Venture Capital based in Germany. Rabab has a major focus on investments in the healthcare sector. Prior to joining Earlybird, Rabab was the program manager at INCUBATE – start-up accelerator at the University of Sydney, Australia. With an extensive research background, Rabab has held roles in leading global research organisations in Australia and the UK, including The George Institute for global health, Lowy Cancer Research Centre, Cancer Research UK, and Cambridge University. Rabab has a PhD in regenerative medicine from UNSW, Australia and CRUK, Manchester. She completed her postdoctoral fellowship at the Babraham Institute, Cambridge, with a focus on therapeutics in the immuno-oncology and auto-immune disease space.